The 19-year-old, who played two Tests for India in October – scoring a century and a half-century – was charged on July 16 after a sample provided back in February showed use of a prohibited substance.
Shaw was found to have Terbutaline in his system, with the Board of Control for cricket in India (BCCI) accepting his explanation that he had ingested it inadvertently via an over the counter cough syrup.
— Prithvi Shaw (@PrithviShaw) July 30, 2019
“On 16th July 2019, Mr. Shaw was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge,” a statement on the BCCI website read.
“The BCCI is satisfied with Mr. Shaw’s explanation that he had taken Terbutaline inadvertently to treat an Respiratory Tract Infection and not as a performance-enhancing drug. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.
“Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr. Shaw’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of eight months should apply, together with disqualification of certain results.”
The ban has been back-dated to the date when the failed sample was collected and, after being adjusted according to BCCI regulations, Shaw’s suspension will run from March 16 to November 15.
Shaw’s sample was taken on February 22 and was then charged by the BCCI on July 16. He, however, played during the Indian Premier League for Delhi Capitals in May. Shaw has not played for India since his last Test against the West Indies in October.
